Tag: Cancer Monoclonal Antibodies Market

Cancer drug attacking cancer cells. 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round). Cetuximab is a chemotherapy drug, used to treat metastatic colon cancer. It acts by inhibiting epidermal growth factor receptor (EGFR), therefore blocking the signals that tell the cancer cells to grow and divide.

Cancer Monoclonal Antibodies Market Size, Growth, Key Players and Forecast

No comments

According to IMARC Group’s latest research report, titled “Cancer Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” presents a comprehensive […]

Read more